Merkel cell carcinoma: An update and review: Current and future therapy.

[1]  T. Meyer,et al.  Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours , 2016, British Journal of Cancer.

[2]  G. Linette,et al.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. , 2016, The Lancet. Oncology.

[3]  J. Decaprio,et al.  Merkel Cell Carcinoma: A Population Analysis on Survival. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  J. Liao,et al.  Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck , 2016, Advances in radiation oncology.

[5]  C. Barker,et al.  Short-Course Radiation Therapy for Merkel Cell Carcinoma: Relative Effectiveness in a “Radiosensitive” Tumor , 2016 .

[6]  B. Coldiron,et al.  Mohs Micrographic Surgery for the Treatment of Merkel Cell Carcinoma , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  P. Nghiem,et al.  Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma , 2016, Cancer medicine.

[8]  D. Merrill,et al.  Merkel Cell Carcinoma Therapeutic Update , 2016, Current Treatment Options in Oncology.

[9]  V. Sondak,et al.  Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base. , 2016, Journal of the National Cancer Institute.

[10]  A. Sober,et al.  Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System , 2016, Annals of Surgical Oncology.

[11]  Drew M. Pardoll,et al.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. , 2016, The New England journal of medicine.

[12]  A. Ghassemi,et al.  Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma. , 2016, Current oncology.

[13]  P. Coursaget,et al.  Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma , 2016, The British journal of dermatology.

[14]  S. Reed,et al.  Perioperative treatment with the new synthetic TLR‐4 agonist GLA‐SE reduces cancer metastasis without adverse effects , 2016, International journal of cancer.

[15]  P. Keegan,et al.  FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1 , 2016, The oncologist.

[16]  Shengli Hao,et al.  Radioactive seed implantation in treatment of an eyelid primary Merkel cell carcinoma. , 2016, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[17]  J. Howle,et al.  Sentinel lymph node biopsy in Merkel cell carcinoma: a 15‐year institutional experience and statistical analysis of 721 reported cases , 2016, The British journal of dermatology.

[18]  A. Ravaud,et al.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.

[19]  F. Mahmoud,et al.  Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma. , 2015, The New England journal of medicine.

[20]  V. Sondak,et al.  Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma , 2015, Cancer.

[21]  T. Fitzgerald,et al.  Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States , 2015, The American surgeon.

[22]  K. Hess,et al.  Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. , 2015, Endocrine-related cancer.

[23]  J. Liao,et al.  Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma , 2015, Cancer medicine.

[24]  P. Coursaget,et al.  Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity , 2015, Neuroendocrinology.

[25]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[26]  K. Hayashi,et al.  Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas. , 2015, Human pathology.

[27]  P. Hegde,et al.  MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer , 2014, Nature.

[28]  Olga K Afanasiev,et al.  Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma , 2014, Cancer Immunology Research.

[29]  W. Kwan,et al.  Outcomes of Merkel Cell Carcinoma Treated with Radiotherapy without Radical Surgical Excision , 2014, Annals of Surgical Oncology.

[30]  J. Brewer,et al.  Merkel Cell Carcinoma in Immunosuppressed Patients , 2014, Cancers.

[31]  V. Sondak,et al.  Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma. , 2014, Journal of the American Academy of Dermatology.

[32]  C. Desmarais,et al.  Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I , 2013, Cancer Immunology Research.

[33]  S. Ibrahim,et al.  18F‐Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Imaging in the Management of Merkel Cell Carcinoma: A Single‐Institution Retrospective Study , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[34]  Olga K Afanasiev,et al.  Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers , 2013, Clinical Cancer Research.

[35]  S. Siva,et al.  18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in the Staging of Merkel Cell Carcinoma: A 15-Year Institutional Experience , 2013, The Journal of Nuclear Medicine.

[36]  Antoni Ribas,et al.  Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.

[37]  P. Devlin,et al.  Palliative Treatment for In-transit Cutaneous Metastases of Merkel Cell Carcinoma Using Surface-Mold Computer-Optimized High-Dose-Rate Brachytherapy , 2013, Cancer journal.

[38]  Luciane T. Kagohara,et al.  PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival , 2013, Cancer Immunology Research.

[39]  D. Rischin,et al.  The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudy. , 2013, International Journal of Radiation Oncology, Biology, Physics.

[40]  P. Tai.  A Practical Update of Surgical Management of Merkel Cell Carcinoma of the Skin , 2013, ISRN surgery.

[41]  D. Kraus,et al.  Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma , 2012, Cancer.

[42]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[43]  L. Misery,et al.  Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  Alison P. Klein,et al.  Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape , 2012, Science Translational Medicine.

[45]  A. Iafrate,et al.  Activation of PI3K Signaling in Merkel Cell Carcinoma , 2012, Clinical Cancer Research.

[46]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[47]  Drew M Pardoll,et al.  Cancer immunotherapy comes of age. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  J. Salleron,et al.  Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. , 2011, Journal of the American Academy of Dermatology.

[49]  A. Chou,et al.  Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. , 2011, Human pathology.

[50]  V. Sondak,et al.  Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. , 2010, Journal of the American Academy of Dermatology.

[51]  D. Galloway,et al.  Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. , 2010, Cancer research.

[52]  V. Gebski,et al.  The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. , 2010, International journal of radiation oncology, biology, physics.

[53]  V. Sondak,et al.  A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin): A Southwest Oncology Group Study (S0331) , 2010, American journal of clinical oncology.

[54]  A. Ng,et al.  Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  J. Lebeau,et al.  Remission of Merkel cell tumor after somatostatin analog treatment. , 2010, Journal of cancer research and therapeutics.

[56]  P. Nghiem,et al.  Radiation monotherapy as regional treatment for lymph node‐positive Merkel cell carcinoma , 2010, Cancer.

[57]  S. Hewitt,et al.  Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. , 2009, International journal of radiation oncology, biology, physics.

[58]  B. Goh,et al.  Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  R. Weichselbaum,et al.  Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. , 2009, Blood.

[60]  S. Lo Vullo,et al.  Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed with Surgery Alone , 2009, Annals of Surgical Oncology.

[61]  P. B. Liao,et al.  Merkel cell carcinoma , 2008, Dermatologic therapy.

[62]  J. Pammer,et al.  Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma , 2008, Modern Pathology.

[63]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[64]  H. Sandler,et al.  Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management , 2007, Cancer.

[65]  P. Nghiem,et al.  Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. , 2007, Journal of the American Academy of Dermatology.

[66]  J. Ellenhorn,et al.  Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  P. Nghiem,et al.  Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. , 2006, Archives of dermatology.

[68]  M. Weinstock,et al.  Adjuvant local irradiation for Merkel cell carcinoma. , 2006, Archives of dermatology.

[69]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[70]  D. Coit,et al.  Merkel cell carcinoma: prognosis and treatment of patients from a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  How-Ran Guo,et al.  Merkel Cell Carcinoma in Patients with Long‐Term Ingestion of Arsenic , 2005, Journal of occupational health.

[72]  Danny Rischin,et al.  High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  D. Brodland,et al.  Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. , 2002, Journal of the American Academy of Dermatology.

[74]  J. Goedert,et al.  Merkel cell carcinoma and HIV infection , 2002, The Lancet.

[75]  R. Roenigk,et al.  A Meta‐analysis of the Prognostic Significance of Sentinel Lymph Node Status in Merkel Cell Carcinoma , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[76]  D. Rischin,et al.  Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. , 2001, International journal of radiation oncology, biology, physics.

[77]  M. Heslin,et al.  Multimodality Treatment of Merkel Cell Carcinoma: Case Series and Literature Review of 1024 Cases , 2001, Annals of Surgical Oncology.

[78]  S. Snow,et al.  Merkel Cell Carcinoma of the Skin and Mucosa: Report of 12 Cutaneous Cases with 2 Cases Arising from the Nasal Mucosa , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[79]  P. Tai,et al.  Merkel Cell Carcinoma of the Skin , 2000, Journal of cutaneous medicine and surgery.

[80]  L. Stitt,et al.  Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  H. Greenway,et al.  Merkel cell carcinoma , 2000, Cancer.

[82]  P. Ziprin,et al.  Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia , 2000, The British journal of dermatology.

[83]  M. First,et al.  Merkel's cell carcinoma in organ recipients: report of 41 cases. , 1999, Transplantation.

[84]  J. Blay,et al.  Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma , 1999, Cancer.

[85]  M. Papotti,et al.  Quantitation of somatostatin receptor type 2 in neuroendocrine (merkel cell) carcinoma of the skin by competitive RT-PCR , 1999 .

[86]  L. Filippini,et al.  [Merkel cell tumor. Report of case and treatment with octreotide]. , 1997, Minerva chirurgica.

[87]  R. Roenigk,et al.  Merkel Cell Carcinoma: Comparison of Mohs Micrographic Surgery and Wide Excision in Eighty‐Six Patients , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[88]  D. Brodland,et al.  Merkel Cell Carcinoma , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[89]  F. Glass,et al.  Merkel Cell Carcinoma Diagnosis and Treatment , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[90]  G. Birrell,et al.  Radiation sensitivity of Merkel cell carcinoma cell lines. , 1995, International journal of radiation oncology, biology, physics.

[91]  D. Ratner,et al.  Merkel cell carcinoma. , 1993, Journal of the American Academy of Dermatology.

[92]  H. Thaler,et al.  Merkel cell carcinoma. Prognosis and management. , 1991, Archives of surgery.

[93]  P. Vermeulen,et al.  Tumor lysis syndrome in a patient with metastatic merkel cell carcinoma , 1991, Cancer.

[94]  G. Larcos,et al.  The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. , 2010, Journal of the American Academy of Dermatology.

[95]  D. Rischin,et al.  Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? , 2006, International journal of radiation oncology, biology, physics.

[96]  L. Norton,et al.  Chemotherapy of metastatic Merkel cell cancer. , 1991, Cancer investigation.